Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice

Obesity is associated with chronic low-grade inflammation that drives the development of metabolic diseases, including non-alcoholic fatty liver disease (NAFLD). We recently showed that white adipose tissue (WAT) constitutes an important source of inflammatory factors. Hence, interventions that atte...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulder, Petra, Morrison, Martine C., Verschuren, Lars, Liang, Wen, van Bockel, J. Hajo, Kooistra, Teake, Wielinga, Peter Y., Kleemann, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992869/
https://www.ncbi.nlm.nih.gov/pubmed/27545964
http://dx.doi.org/10.1038/srep31542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992869/
https://www.ncbi.nlm.nih.gov/pubmed/27545964
http://dx.doi.org/10.1038/srep31542

Ejemplares similares